Ways2Capital Reviews : USFDA Clearance To Dr. Reddy’s API Plant At Srikakulam SEZ

Dr. Reddy’s Laboratories has announced that its API plant at Srikakulam, Andhra Pradesh has completed USFDA audit with zero observations. This is not the same plant, which has an outstanding warning letter since November-2015.

The plant which has received warning letter is yet to come out of the regulatory action and in February 2018 company had said that the plant continues to remain under official action indicated (OAI) status. The OAI is issued when there are objectionable conditions found at the manufacturing facility.

Dr Reddys Laboratories Ltd is currently trading at Rs2,004.50 up by Rs63.05 or 3.25% from its previous closing of Rs1,941.45 on the BSE.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626191 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717
Share on Google Plus Share on Pinterest

About Bhoomi Desai